ProGRP(Pro-Gastrin-Releasing Peptide) Compitable instrument: Luminex 200,TESMI F4000 . Reference Value: ≤62.8pg/mL Tellgen also provide following Tumor markers and Tumor Marker control : CA125 CA153 CA24-2 CYFRA21-1 AFP CEA CEA total PSA free PSA free-beta-hCG CA19-9 NSE SCCA CA72-4 CA50 HE4 ProGRP PGI/PGII Control 1 Control 2 Control 3 Progastrin-releasing peptide (ProGRP) is a biomarker which is overexpressed in SCLC, with elevated levels occurring primarily in the blood of patients with this form of lung cancer. The ProGRP test is an important diagnostic tool, as it can help clinicians determine the appropriate treatment pathway. Studies have shown that ProGRP can also identify early-stage SCLC and help to distinguish SCLC from benign lung diseases.

Shanghai Tellgen Corporation. was founded in 2003 and dedicated exclusively to the development, production and distribution of high-quality automated workflow solutions for research and clinical diagnostics laboratories in the life sciences sector. With the tremendous development, Tellgen became the the market leader in moleucular diagnosis area, and had consistently delivered series diagnostic products for healthcare